Most peptide buys go in the wrong order. Land on a vendor page, skim the product copy, eyeball the price, hit checkout. Research happens after the box arrives, if at all. That sequence is exactly how people end up with bunk vials, the wrong peptide for the use case, and an 8-week protocol on one 5 mg vial. Show me the COA or it didn't happen, sure, but show me the mechanism and the evidence first.
Flip the order. Mechanism first. Evidence second. Dosing third. Vendor and price fourth. Purchase last. Each step uses free tools, most of them on the Next Pep platform. Whole thing takes 15-30 minutes per peptide and saves way more than that in avoided wrong-order mistakes, mis-ordered vials, and wasted doses.
Key Takeaways
- —FDA enforcement data (2025) found up to 40% of online peptides contain incorrect dosages, and you can only catch that gap if you check before buying.
- —A research-first workflow puts mechanism, evidence, and dosing ahead of vendor and price, the reverse of how most people actually shop.
- —Free tools for every step: Next Pep library for mechanism/evidence, comparison tool for substitute evaluation, dosing calculator for reco math, URL-import for COA verification.
- —No signup needed for any step, all research tools are free and browser-based.
- —The where-to-buy guide covers the vendor vet step in full with a 9-criterion scorecard.
Before you care what a peptide costs, you need to care what it does. First question: does this peptide actually act through the mechanism I think it does, for the outcome I'm targeting?
Every peptide in the Next Pep library has a mechanism section that covers:
Quick example. BPC-157 gets called a "healing peptide" everywhere, which is technically right in preclinical models and uselessly broad in practice. The BPC-157 research profile names the four verified mechanisms (VEGFR2-PI3K-Akt-eNOS angiogenesis, Src-caveolin-1-eNOS angiogenesis, FAK-paxillin cell migration, GHR upregulation) and which tissues each one applies to. Someone running BPC-157 for an Achilles tendon has a different dominant mechanism than someone running it for gut mucosal repair, same peptide, different active piece. Near the site, not in the joint, depending on which one you're after.
Mechanism step usually takes 3-5 minutes in the library. If it's taking longer, the mechanism is probably overcomplicated for the decision you're making.
Once mechanism lines up with your use case, check evidence depth. Not all "peptide evidence" is the same evidence.
Evidence tiers, top to bottom:
Every research profile explicitly tags the evidence tier its claims sit at. If a peptide's strongest data is preclinical, that's stated plainly. If it's Phase III, same.
Rarely is there only one peptide that could answer your question. BPC-157 has TB-500 as a mechanistic complement and GHK-Cu as a partial substitute for tissue repair. Ipamorelin has CJC-1295 as a non-substitute but necessary complement for GH-axis work. PT-141 is the only peptide with FDA approval for HSDD, but tadalafil is a non-peptide alternative working on a different mechanism entirely.
The comparison tool at /compare puts up to 4 peptides side-by-side on mechanism, PK, evidence, dosing, safety, and regulatory status. A few common compare-or-complement calls the tool handles cleanly:
If the comparison turns up a clearly better option for your specific case, switch targets before you spend a dollar.
How many vials you need depends on your target dose and cycle length. Running the math before you order kills the classic "I bought one vial and the protocol needs six" mistake.
The Next Pep dosing calculator takes four inputs:
And spits out:
A 4-8 week BPC-157 cycle at 250 mcg × 2 daily runs ~6-12 mg total. That's 2-3 × 5 mg vials. Ordering one 5 mg vial and planning an 8-week cycle is a mismatch the calculator catches in under a minute.
Only after the first four steps does vendor vetting actually matter. The where-to-buy-peptides guide walks through this with a 9-criterion weighted scorecard:
Fastest piece of this: paste any vendor product URL into the Next Pep library search. The URL-import extractor pulls the vendor's stated data in 20-40 seconds, name, molecular data, dosing context, COA references, any lab-report URLs. If the extractor can't find a COA link, red flag. If the stated molecular formula doesn't match PubChem's entry, red flag. If the dosing context is implausible, red flag. Stock photos and zero testing is the obvious one, the subtler ones are where most people get caught.
All of this happens before money changes hands.
User wants to support tendon repair after an Achilles injury. They've heard of BPC-157 but aren't sure where to start.
Step 1 (3 min): Read the BPC-157 research profile. Mechanism is tissue repair via angiogenesis and cell migration, aligned with tendon healing.
Step 2 (4 min): Evidence depth: 35 preclinical rodent/dog studies, 1 human safety pilot. Not top-tier human evidence, but plausible mechanism-to-use-case alignment.
Step 3 (3 min): Compare BPC-157 against TB-500. TB-500 is a mechanistic complement for tendon work (systemic vs local). User decides to start with BPC-157 alone, TB-500 is a possible add-on for a later cycle if results aren't enough. Wolverine stack on deck for round two.
Step 4 (4 min): Calculate dosing. Protocol: 250 mcg × 2 per day for 6 weeks. Total = ~21 mg. Needs 3 × 5 mg vials (or 2 × 10 mg vials, often cheaper per mcg).
Step 5 (10 min): Paste two candidate vendor URLs into library search. One has a third-party COA with a lab-verifiable report ID, one has only an in-house "purity statement" and no batch number. User picks the verified vendor, orders 3 × 5 mg vials, has the full reco protocol written up before the order ships.
Elapsed time: ~25 minutes. Cost of running the workflow vs skipping it: the one avoided wrong-peptide purchase alone more than pays for the time.
For a peptide you're unfamiliar with: 20-30 minutes. For one you already know: 5-10 minutes (the comparison and dosing steps). Time cost is way smaller than the typical cost of a wrong-order mistake, especially when shipping from CN means you're waiting 2-3 weeks to find out the vials are bunk.
No. The library, comparison tool, and dosing calculator are free, browser-based, no signup. The URL-import feature works for anyone using the library search bar.
Paste the vendor URL into the library search bar. The URL-import extractor adds it to the library in 20-40 seconds with structured data pulled from the vendor page. From there you can run steps 1-4 on the imported entry.
No. Next Pep doesn't sell peptides and doesn't take affiliate commissions that influence vendor display order. The 9-criterion scorecard is a framework you apply yourself, we don't score or rank vendors for you. G2G is something you decide, not something we tell you.
That's the workflow doing its job. Better to find that at step 1 (free) than at step 5 (after purchase, with unusable vials sitting in your fridge). Check if there's a mechanistic alternative via the comparison tool, or take a hard look at whether a peptide intervention is the right call at all.
This article is for research and informational purposes only. Research peptides are not FDA-approved for human clinical use. Consult a licensed healthcare professional before considering any peptide protocol.
Research Disclaimer. All content on Next Pep is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before considering any peptide protocol.
CJC-1295 with DAC has a 6-8 DAY half-life; Modified GRF (1-29) clears in ~30 minutes. Same modified GHRH(1-29) backbone, one bolt-on linker, ~1,000x PK difference.
TB-500 is a 7-aa fragment of thymosin beta-4 (43 aa, ~4,963 Da), not the full protein. Cross-COA review: ~67% of "TB-500" vials are actually full Tβ4.